2019
DOI: 10.1002/ejhf.1644
|View full text |Cite
|
Sign up to set email alerts
|

Selenium and outcome in heart failure

Abstract: Severe deficiency of the essential trace element selenium can cause myocardial dysfunction although the mechanism at cellular level is uncertain. Whether, in clinical practice, moderate selenium deficiency is associated with worse symptoms and outcome in patients with heart failure is unknown.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
115
1
9

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 103 publications
(130 citation statements)
references
References 37 publications
5
115
1
9
Order By: Relevance
“…Supportive measures aimed at improving selenoprotein biosynthesis in COVID-19 may enable a better redox control and fine-tuned response of the immune system [41]. It appears meaningful, timely, and promising to initiate population-wide measures trying to identify subjects with pre-existing Se deficits, not just as a preventive measure for viral infections, spread, and virulence development [11,12,42], but also to reduce the individual risk for cardiovascular mortality [44][45][46][47], cancer [21,48,49], and death from severe disease [10,14,39]. infections, spread, and virulence development [11,12,42], but also to reduce the individual risk for cardiovascular mortality [44][45][46][47], cancer [21,48,49], and death from severe disease [10,14,39].…”
Section: Discussionmentioning
confidence: 99%
“…Supportive measures aimed at improving selenoprotein biosynthesis in COVID-19 may enable a better redox control and fine-tuned response of the immune system [41]. It appears meaningful, timely, and promising to initiate population-wide measures trying to identify subjects with pre-existing Se deficits, not just as a preventive measure for viral infections, spread, and virulence development [11,12,42], but also to reduce the individual risk for cardiovascular mortality [44][45][46][47], cancer [21,48,49], and death from severe disease [10,14,39]. infections, spread, and virulence development [11,12,42], but also to reduce the individual risk for cardiovascular mortality [44][45][46][47], cancer [21,48,49], and death from severe disease [10,14,39].…”
Section: Discussionmentioning
confidence: 99%
“…Supportive measures aimed at improving selenoprotein biosynthesis in COVID-19 may enable a better redox control and fine-tuned response of the immune system [38]. It appears meaningful, timely and promising to initiate population-wide measures trying to identify subjects with pre-existing Se deficits, not just as preventive measure for viral infections, spread and virulence development [11,12,39], but also to reduce the individual risk for cardiovascular mortality [41][42][43][44], cancer [21,45,46], and death from severe disease [10,14,36]. Infections by SARS-CoV-2 occur largely independent from baseline Se status.…”
Section: Discussionmentioning
confidence: 99%
“…В организме человека селен входит в состав порядка 30 биологически активных соединений (ферменты антиоксидантной системы, гормоны, липиды), участвует в метаболизме нуклеиновых кислот и регуляции действия тиреоидных гормонов [7][8][9]. Селен имеет важное значение для нормальной работы иммунной и антиоксидантной систем организма, защищающих от неблагоприятного воздействия окружающей среды, т. к. является необходимым компонентом системы, регулирующей количество свободных радикалов, которые образуются в организме физиологически, а также в результате патологических процессов [9,23].…”
Section: Discussionunclassified
“…Очевидно, что дефицит селена вызовет нарушение работы антиоксидантной системы и повреждение клеток организма свободными радикалами. Недостаточность селена может провоцировать патологию разных органов и систем, вызывать злокачественные заболевания [9,23,24]. Дефицит Se приводит к болезни Кашина-Бека (остеоартроз с множественной деформацией суставов, позвоночника и конечностей), болезни Кешана (эндемическая миокардиопатия), анемии, наследственной тромбастении [9,25].…”
Section: Discussionunclassified